Neotracin500 units + 3.5 mg + 5000 IU + 40 mg

Ointment

Bacitracin + Neomycin Sulphate + Polymyxin B Sulphate + Lidocaine

Ointment

Neotracin

500 units + 3.5 mg + 5000 IU + 40 mg

Bacitracin + Neomycin Sulphate + Polymyxin B Sulphate + Lidocaine

Topical antibacterial with a local anaesthetic for minor skin infections.

Ask about this product Product information

Export fast-track. DRAP export registration in about a month for products developed against export orders. Describe the formulation

Generic composition: Bacitracin + Neomycin Sulphate + Polymyxin B Sulphate + Lidocaine
Strength: 500 units + 3.5 mg + 5000 IU + 40 mg
Dosage form: Ointment
Pack sizes: 10 gm

Manufacturer: Paramount Pharmaceuticals, Islamabad
Licence: DML 000439 · DRAP GMP
Release: Batch-tested, with Certificate of Analysis

For healthcare professionals. Registration status, brand names and pack presentations vary by market. Experienced a side effect? Report it here.

Neotracin

How it's made

Creams, gels and ointments are made by preparing and emulsifying the bases, then mixing in the active ingredient. Made in the general production section.

How all our dosage forms are made →

01
Dispensing
Each raw material is released by QC, then weighed for the batch under a second person's check.
02
Phase preparation
Oil and water phases are heated and prepared separately.
03
Emulsifying
The phases are combined and homogenised, then the active ingredient is added and evenly mixed.
04
Tube filling
Product is filled into tubes to a set weight and the tubes are crimped and coded.

Batch release tests

Fill weight
Assay of the active ingredient
pH
Viscosity and appearance
Microbial limits

Limits for this product are on each batch's Certificate of Analysis.

Dermatology

Related medicines

All Dermatology →

Neotracin500 units + 3.5 mg + 5000 IU + 40 mg

How it's made

Dispensing

Phase preparation

Emulsifying

Tube filling

Batch release tests

Related medicines